Is the New Ebola Bundibugyo Strain from a Spillover Event Adapted for Better Cell Entry and Airborne Transmission?
Nikhil Prasad Fact checked by:Thailand Medical News Team May 28, 2026 44 minutes ago
Editorial: A growing controversy is emerging among virologists and infectious disease experts after newly uploaded genomic sequences linked to the current Bundibugyo Ebola outbreaks in the Democratic Republic of Congo and Uganda revealed a series of unusual mutations that are now fueling concerns about viral adaptation and enhanced transmissibility.
Scientists are closely monitoring alarming mutations in newly sequenced Bundibugyo Ebola strains from Uganda and Congo
The World Health Organization-linked laboratories recently deposited several genomic sequences from the latest Bundibugyo Ebola strains onto the Virological and Pathoplexus databases.
https://www.thailandmedical.news/news/initial-genomic-sequencing-data-shows-that-bundibugyo-ebola-outbreak-in-drc-is-a-genetically-distinct-new-spillover
However, scientists monitoring the data say that very little public commentary has accompanied the releases, apart from brief statements suggesting that the outbreak likely originated from a fresh spillover event rather than from lingering transmission chains connected to older outbreaks.
There are speculations that the WHO while trying to portray themselves being global health leaders with meaningful goals are actually withholding data that they do not want countries like the United States that has left the WHO to have access to.
Troubling Mutations Raise Questions
Anonymous scientific sources familiar with preliminary genomic analyses claim that the new strains may contain several mutations associated with altered viral behavior. Among the most discussed is the GP-A82V mutation involving the viral glycoprotein.
Earlier Ebola research had already associated changes in the glycoprotein region with enhanced cell entry efficiency and greater infectivity in human cells.
https://www.umassmed.edu/news/articles/archives/2016/11/umms-study-suggests-ebola-virus-mutation-caused-recent-outbreak/
Although no official statement has confirmed the biological impact of the mutation in the current Bundibugyo strains, experts warn that such changes cannot be ignored. Some researchers suspect that the virus may be undergoing adaptive evolution as it circulates between both animal hosts and humans.
One particularly intriguing finding involves the Uganda sequence designated PP_006XCJJ. Researchers noted a short tract of four T→C mutations occurring at genomic positions 4165, 4167, 4177, and 4191.
https://virological.org/t/initial-genomes-from-may-2026-bundibugyo-virus-disease-outbreak-in-the-democratic-republic-of-the-congo-and-uganda/1032
While mu
tation clusters have appeared in earlier Ebola outbreaks, some molecular biologists speculate that this pattern could reflect selective pressure acting on receptor interactions or viral replication pathways.
There are speculations that these new mutations allow the new Ebola strains to use newer human receptors and cell components for entry
Could Airborne Adaptation Be Emerging?
At present, there is absolutely no validated evidence proving that the new Bundibugyo strain has become airborne in humans. However, the unusual mutation patterns are reigniting a long-running scientific debate that many believed had been settled years ago.
For decades, some virologists insisted that Ebola viruses evolved relatively slowly despite being RNA viruses. Others argued that Ebola lacked the biological capacity to adapt toward improved aerosol transmission. Modern laboratory research and animal-model studies over the last decade have increasingly challenged those assumptions, showing that filoviruses possess far greater evolutionary flexibility than previously believed.
This
Medical News report notes that several scientists are now worried that continued human-to-human transmission during expanding outbreaks may provide the virus with more opportunities to accumulate adaptive mutations. The concern is amplified by the fact that the current outbreak is occurring across regions with porous borders and ongoing population movement.
Concerns Over Data Restrictions
Another source of controversy involves accusations that important genomic data are being selectively restricted. Some observers claim that WHO-linked institutions are limiting broader access to detailed sequence analyses through restricted-use databases, even while publicly denying that information is being withheld.
The newly released genomes appear on Pathoplexus under restricted public health use conditions, adding to concerns among independent researchers who say greater transparency is needed during rapidly evolving outbreaks.
https://pathoplexus.org/news/2026-05-19-ebola-bundibugyo
Meanwhile, Uganda and Congo continue to report infections associated with the Bundibugyo strain, a species first identified during a deadly outbreak in western Uganda in 2007. Historical analyses previously showed that earlier Bundibugyo outbreaks also likely resulted from separate spillover events originating from natural reservoirs rather than continuous viral persistence.
Experimental Therapies Could Add Evolutionary Pressure
Some infectious disease specialists are also quietly voicing concerns over the planned deployment of experimental monoclonal antibody therapies in the DRC outbreak.
https://www.theeastafrican.co.ke/tea/sustainability/health/congo-seeks-us-monoclonal-antibody-for-bundibugyo-ebola-strain-5475894
They warn that incomplete viral neutralization under therapeutic pressure could theoretically encourage additional mutations, particularly if treatments are administered widely during active transmission chains.
Similar evolutionary debates emerged during the SARS-CoV-2 pandemic, where selective pressures from immune responses, antiviral therapies, and population immunity contributed to the rapid emergence of new variants.
While no evidence currently suggests that the new Bundibugyo strains are capable of sustained airborne spread, experts stress that dismissing the possibility of enhanced transmissibility would be scientifically irresponsible. The combination of fresh spillover events, expanding human transmission, unusual mutation clusters, and potential glycoprotein adaptations means the outbreak deserves far more intensive genomic surveillance and transparent international collaboration before definitive conclusions can be reached.
The current panic and overwhelming concerns on the current Ebola outbreak in DRC which is actually its 17
th outbreak to date, indicates that certain government and health officials around the world know what is at stake and that there is something definitely not right.
For the latest Ebola news, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/ebola
Share
Tweet
Share
